- Home
- LPCN vs AMST Comparison
LPCN vs AMST Comparison
Compare LPCN & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- AMST
- Stock Information
- Founded
- LPCN 1997
- AMST 2017
- Country
- LPCN United States
- AMST United States
- Employees
- LPCN N/A
- AMST N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- AMST Computer Software: Prepackaged Software
- Sector
- LPCN Health Care
- AMST Technology
- Exchange
- LPCN Nasdaq
- AMST Nasdaq
- Market Cap
- LPCN 16.1M
- AMST 13.3M
- IPO Year
- LPCN N/A
- AMST 2020
- Fundamental
- Price
- LPCN $2.95
- AMST $2.83
- Analyst Decision
- LPCN Strong Buy
- AMST
- Analyst Count
- LPCN 2
- AMST 0
- Target Price
- LPCN $9.00
- AMST N/A
- AVG Volume (30 Days)
- LPCN 36.3K
- AMST 45.4K
- Earning Date
- LPCN 08-05-2025
- AMST 09-29-2025
- Dividend Yield
- LPCN N/A
- AMST N/A
- EPS Growth
- LPCN N/A
- AMST N/A
- EPS
- LPCN N/A
- AMST N/A
- Revenue
- LPCN $4,208,119.00
- AMST $82,544.00
- Revenue This Year
- LPCN N/A
- AMST N/A
- Revenue Next Year
- LPCN N/A
- AMST N/A
- P/E Ratio
- LPCN N/A
- AMST N/A
- Revenue Growth
- LPCN N/A
- AMST N/A
- 52 Week Low
- LPCN $2.68
- AMST $2.00
- 52 Week High
- LPCN $6.17
- AMST $6.27
- Technical
- Relative Strength Index (RSI)
- LPCN 37.54
- AMST 41.47
- Support Level
- LPCN $2.92
- AMST $2.78
- Resistance Level
- LPCN $3.25
- AMST $3.02
- Average True Range (ATR)
- LPCN 0.19
- AMST 0.17
- MACD
- LPCN -0.04
- AMST -0.04
- Stochastic Oscillator
- LPCN 4.41
- AMST 13.85
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.